Burghardt Wittig – Trademark Portfolio
Entity Type: 01
Burghardt Wittig holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SLISUR, NUACRES, and ALTINADISUR.
Salzachstr. 33
14129 Berlin
Showing of trademarks Trademarks
Trademark Classifications
Burghardt Wittig's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Burghardt Wittig have?
Burghardt Wittig has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Burghardt Wittig file in?
Burghardt Wittig files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Burghardt Wittig's most well-known trademarks?
Burghardt Wittig's registered trademark portfolio includes well-known marks such as SLISUR, NUACRES, and ALTINADISUR. These are among 3 currently registered trademarks in the portfolio.
What is Burghardt Wittig's trademark registration success rate?
Burghardt Wittig has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.